PROKIDNEY CORP.
For the period ended Mar 18, 2026. Filed Mar 18, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 18, 2026 · Filed Mar 18, 2026
Use the contents to explore the available documents and sections.
PROK$1.14+7.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except for share data)
(in thousands, except for share data)
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Cash and cash equivalents | $108,537 | $99,120 |
| Marketable securities | 161,480 | 259,172 |
| Interest receivable | 1,127 | 2,447 |
| Prepaid assets | 2,808 | 4,192 |
| Prepaid clinical | 3,923 | 11,505 |
| Assets held for sale | – | 19,368 |
| Other current assets | 2,804 | 80 |
| Total current assets | 280,679 | 395,884 |
| Fixed assets, net | 51,231 | 42,222 |
| Right of use assets, net | 3,664 | 2,967 |
| Total assets | $335,574 | $441,073 |
| Liabilities and Stockholders' Deficit | ||
| Accounts payable | $940 | $3,633 |
| Lease liabilities | 1,071 | 765 |
| Accrued expenses and other | 28,731 | 31,137 |
| Income taxes payable | – | 682 |
| Total current liabilities | 30,742 | 36,217 |
| Income tax payable, net of current portion | 1,074 | 748 |
| Lease liabilities, net of current portion | 2,965 | 2,471 |
| Total liabilities | 34,781 | 39,436 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interest | 1,311,990 | 1,396,591 |
| Stockholders’ deficit | ||
| Class A common stock, $0.0001 par value; 700,000,000 and 500,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; 141,807,277 and 128,054,417 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 14 | 13 |
| Class B common stock, $0.0001 par value; 500,000,000 shares authorized; 159,262,779 and 163,693,707 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 16 | 16 |
| Additional paid-in capital | 258,552 | 205,736 |
| Accumulated other comprehensive gain | 56 | 130 |
| Accumulated deficit | (1,269,835) | (1,200,849) |
| Total stockholders' deficit | (1,011,197) | (994,954) |
| Total liabilities and stockholders' deficit | $335,574 | $441,073 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.